Journal Article Summary
The article investigates the potential link between the medication indapamide and the serious condition known as rhabdomyolysis, which involves the rapid breakdown of muscle tissue. This topic is important because rhabdomyolysis can lead to severe complications, including kidney damage, and is associated with electrolyte imbalances such as low potassium (hypokalaemia) and low sodium (hyponatraemia). Understanding the risks associated with indapamide, a diuretic commonly used to treat high blood pressure, is crucial for healthcare providers and patients alike.
The researchers analyzed case reports from VigiBase, a global database of drug-related adverse effects, focusing on instances where indapamide was suspected to cause rhabdomyolysis. They found 28 unique cases from 13 countries, with many of these cases also reporting hypokalaemia or hyponatraemia. The study applied the Bradford Hill criteria to assess causality, concluding that there is a significant association between indapamide use and rhabdomyolysis, particularly in patients with additional risk factors like concurrent medications that can lower potassium levels or excessive liquorice consumption.
However, the study has limitations, including the inherent challenges of spontaneous reporting systems, which may lead to underreporting of adverse events and lack of detailed patient information. Patients should be aware of the potential risks of rhabdomyolysis when taking indapamide, especially if they have other conditions or are taking medications that affect electrolyte levels. It is advisable for individuals to discuss any concerns or symptoms with their healthcare provider, who can help monitor their health and adjust treatment as necessary.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Yue Qun-Ying, Caduff-Janosa Pia. Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria. Drugs – Real World Outcomes 2022. DOI: 10.1007/s40801-022-00295-6. PMID: 35235186. PMCID: PMC9114225.
Featured Pill Pals Product
Indapamide 1.25 mg Tablets --- Generic For Lozol --- ANI Pharma
Indapamide 1.25 mg Tablets — Generic For Lozol — ANI Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
